36 studies found for:    Open Studies | "Carcinoid Tumor"
Show Display Options
Rank Status Study
21 Available 68Ga DOTA-TATE PET/CT in Somatostatin Receptor Positive Tumors
Conditions: Carcinoid Tumors;   Islet Cell (Pancreatic NET);   Other Neuroendocrine Tumors
Intervention: Drug: 68Ga-DOTA TATE
22 Unknown  123I-MIBG Scintigraphy in Patients Being Evaluated for Neuroendocrine Tumors
Conditions: Pheochromocytoma;   Neuroblastoma;   Paraganglioma;   Medullary Thyroid Carcinoma;   Carcinoid Tumors
Intervention: Drug: 123I-meta-iodobenzylguanidine
23 Recruiting RegisterNET - A Registry for Neuroendocrine Tumors in the USA
Conditions: Neuroendocrine Tumor;   Carcinoid;   Neuroendocrine Carcinoma
Intervention: Device: NETest
24 Available 68Ga DOTATATE PET/CT in Neuroendocrine Tumors (Expanded Access)
Conditions: Carcinoid Cancer;   Neuroendocrine Tumors;   Medullary Thyroid Cancer;   Cancers Expressing Somatostatin Receptors
Intervention: Drug: 68Ga DOTATATE
25 Recruiting A Ph 2 Study of Fosbretabulin in Subjects w Pancreatic or Gastrointestinal Neuroendocrine Tumors w Elevated Biomarkers
Condition: Neuroendocrine Tumors
Intervention: Drug: fosbretabulin tromethamine
26 Not yet recruiting Randomized Phase III of PRRT Versus Interferon
Condition: Gastro-intestinal Neuroendocrine Tumors
Interventions: Drug: Interferon alpha-2b;   Drug: 177Lu-DOTATATE
27 Unknown  Relationship Between Platinum Levels in the Blood and Neurotoxicity in Patients Who Are Receiving Oxaliplatin for Gastrointestinal Cancer
Condition: Cancer
Interventions: Drug: oxaliplatin;   Procedure: management of therapy complications
28 Recruiting Recombinant Anti-tumor and Anti-virus Protein for Injection to Treat Advanced Neuroendocrine Tumors
Condition: Neuroendocrine Tumors
Intervention: Drug: Recombinant anti-tumor and anti-virus protein for injection (Novaferon)
29 Recruiting Biomarkers in Patients With Respiratory Tract Dysplasia or Lung Cancer, Head and Neck Cancer, or Aerodigestive Tract Cancer and in Normal Volunteers
Conditions: Esophageal Cancer;   Head and Neck Cancer;   Lung Cancer;   Precancerous Condition
Interventions: Other: immunohistochemistry staining method;   Other: laboratory biomarker analysis;   Other: sputum cytology;   Procedure: biopsy
30 Unknown  Comfort Level of Two Abdominal Compression Methods Used to Hold Patients Still While Undergoing Stereotactic Body Radiation Therapy for Lung Tumors
Condition: Lung Cancer
Interventions: Other: questionnaire administration;   Procedure: computed tomography;   Radiation: radiation therapy treatment planning/simulation
31 Unknown  DNA Analysis of Blood and Tissue From Patients With Lung Cancer
Condition: Lung Cancer
Interventions: Genetic: polymerase chain reaction;   Genetic: polymorphism analysis;   Other: diagnostic laboratory biomarker analysis
32 Unknown  External-Beam Radiation Therapy With or Without Indinavir and Ritonavir in Treating Patients With Brain Metastases
Condition: Cancer
Interventions: Drug: indinavir sulfate;   Drug: ritonavir;   Radiation: radiation therapy
33 Recruiting Everolimus Roll-over Protocol for Patients Who Have Completed a Previous Novartis-sponsored Everolimus Study.
Condition: Neoplasms
Interventions: Drug: Everolimus;   Drug: Sandostatin LAR Depot
34 Recruiting Phase II Study of Subcutaneous Injection Depot of Octreotide in Patients With Acromegaly and Neuroendocrine Tumours (NETs)
Conditions: Acromegaly;   Neuroendocrine Tumors
Intervention: Drug: octreotide FluidCrystal® injection depot
35 Unknown  Oral Glucose Tolerance Testing (OGTT) on Patients Taking Somatostatin Analogs
Condition: Acromegaly
Intervention: Other: Oral Glucose Tolerance Test (OGTT)
36 Recruiting Carfilzomib for the Treatment of Patients With Advanced Neuroendocrine Cancers
Condition: Neuroendocrine Cancer
Intervention: Drug: Carfilzomib

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-36) Next Page   
Indicates status has not been verified in more than two years